October, 2023 – BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today Read More
‘United for Breast Cancer – A Commitment for Excellence and Innovation’ aims to address critical areas in breast cancer diagnosis, management, Read More